PGIM ETF Trust - PGIM Jennison International Opportunities ETF (PJIO) Stock Price

59.6441 ▼ -0.9664 (-1.59%)
Open: 60.0452 Vol: 1.11K Day's range: 59.64 - 60.0452 Jun 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PJIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 60.62▲ 60.62▲ 60.73▲ 60.59▼ 60.25▼
MA10 60.63▲ 60.64▲ 60.49▲ 60.68▼ 57.89▲
MA20 59.39▲ 58.98▲ 58.13▲ 60.42▼ 56.82▲
MA50 N/A     N/A     N/A     56.84▲ 55.95▲
MA100 N/A     N/A     N/A     56.59▲ N/A    
MA200 N/A     N/A     N/A     56.05▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ 0.103▲ 0.329▲ -0.263▼ 0.609▲
RSI 64.684▲ 64.619▲ 63.557▲ 51.458▲ 58.240▲
STOCH 57.053     64.330     92.296▲ 48.224     94.518▲
WILL %R 0.000▲ 0.000▲ 0.000▲ -99.789▼ -10.481▲
CCI 166.996▲ 116.135▲ 75.363     -149.518▼ 82.614    
Latest Filters Detected On PJIO
MA $PJIO Price Crossed Below MA(26) Set Alert
▼ BREAK $PJIO Price Breaks 10 Days Low Set Alert
CDL $PJIO Marubozu Candlestick Pattern Detected Set Alert
PGIM ETF Trust - PGIM Jennison International Opportunities ETF News
Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio
Friday, June 06, 2025 04:45 AM
Marlborough, Massachusetts--(Newsfile Corp. - June 6, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...
Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio
Friday, June 06, 2025 04:45 AM
Lisa Carson named as new VP, Finance and AdministrationMarlborough, Massachusetts--(Newsfile Corp. - June 6, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA ...
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Thursday, May 01, 2025 12:45 AM
About Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company advancing its INTASYL ® gene silencing technology focused on immuno ...
PJIO historical stock data
date open high low close volume
13/06/25 60.0452 60.0452 59.64 59.6441 1,106
12/06/25 60.76 60.76 60.5928 60.6105 492
11/06/25 61.28 61.28 60.8145 60.8145 461
09/06/25 61.58 61.58 60.6961 60.6961 1,983
06/06/25 61.127 61.25 61.127 61.199 600
05/06/25 61.43 61.43 61.151 61.151 400
04/06/25 61.16 61.16 61.0806 61.0806 3,339
03/06/25 60.6705 60.6705 60.6705 60.6705 218
02/06/25 60.72 60.72 60.6879 60.6879 3,620
30/05/25 60.203 60.203 60.203 60.203 100
Quote Details
52wk Low:43.11
52wk High:61.58
Vol:1.11K
Avg Vol(3m):30K
1Y Chng:+6.72%
1M Chng:+5.51%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00